Jacob Fuqua
Hematology & Oncology · Louisville, KYNPI 1518490499
Payments from drug & device makers
Across 41 payments — averaging $44.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$440
- Johnson & Johnson$314
- Bristol Myers Squibb$167
- AstraZeneca$127
- Blueprint Medicines Corporation$109
- Tempus AI, Inc$80
- plus $580 from 19 others
What the payments were for
- Food & beverage$1,73996%
- Education$784%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $440 |
| Johnson & Johnson | 4 | $314 |
| Bristol Myers Squibb | 2 | $167 |
| AstraZeneca(2 entities) | 3 | $127 |
| Blueprint Medicines Corporation | 1 | $109 |
| Tempus AI, Inc | 1 | $80 |
| Merck | 4 | $74 |
| AbbVie | 2 | $60 |
| Novartis | 2 | $54 |
| Incyte Corporation | 2 | $50 |
| Alnylam Pharmaceuticals Inc. | 2 | $48 |
| Geron Corporation | 1 | $42 |
| Boehringer Ingelheim | 1 | $30 |
| Sanofi | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Immunocore Limited | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Array Biopharma Inc | 1 | $14 |
| Recordati_rare_diseases_inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,817 in reported general payments places this provider in the 15th percentile of 143 hematology & oncology providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 19 | $171 |
| Prochlorperazine Maleate | 11 | $141 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Louisville
- Joseph MalyLouisville$7M
- Laila AgrawalLouisville$6.3M
- Jaspreet GrewalLouisville$4.2M
- Rebecca RedmanLouisville$2.1M
- Vivek SharmaLouisville$1.9M
- Rohit KumarLouisville$1.6M
- Jeffrey HargisLouisville$1.3M
- Goetz KloeckerLouisville$1.2M
- Elizabeth RileyLouisville$746K
- Adam LyeLouisville$706K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.